Ki-67 and S100A11 immunostaining demonstrated decreased proliferation in S100A11-silenced tumours, as indicated by lower Ki-67 expression (Fig. 3G), whereas tumours overexpressing S100A11 revealed increased Ki-67 levels indicating enhanced proliferation (Fig. 3H). Here, S100A11 is linked to neoplasm.